Azithromycin-induced block of elementary body formation in Chlamydia trachomatis.
The mechanism of action of azithromycin on the murine strain of Chlamydia trachomatis grown in tissue culture epithelial cells is addressed. Azithromycin at a concentration of 100 ng/ml inhibits chlamydial growth in tissue culture, a value that agrees well with prior in vitro data from human strains of C. trachomatis grown in tissue culture. By morphological criteria, the block to chlamydial growth appears to occur early in its life cycle. Azithromycin is not directly toxic to chlamydial elementary bodies but does inhibit chlamydial protein synthesis in chlamydia-infected cells. This inhibition appears quite general in nature and is rapid. It is further shown that azithromycin does not directly inhibit mRNA synthesis. Azithromycin blocks chlamydial protein synthesis in host cell-free chlamydial reticulate bodies in a manner similar to its inhibition in infected cells, albeit at slightly higher concentrations. The inhibition of chlamydial protein synthesis following a brief exposure to azithromycin is more long lasting than that following a brief exposure to erythromycin.
D000818:Animals; D017963:Azithromycin; D001426:Bacterial Proteins / Q000096:biosynthesis; D002692:Chlamydia trachomatis / Q000187:drug effects* / Q000254:growth & development; D046508:Culture Techniques; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000494:pharmacology; D051379:Mice; D012329:RNA, Bacterial / Q000187:drug effects
D001426:Bacterial Proteins; D012329:RNA, Bacterial; D004917:Erythromycin; D017963:Azithromycin